Navigation Links
Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma

and all other statements that are not purely historical in nature, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "project," "should," "will," "would" and similar expressions are intended to identify forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks and uncertainties relating to: our ability to successfully market and sell ZYFLO CR, including the success of our co-promotion arrangement with DEY; our ability to develop and maintain the necessary sales, marketing, distribution and manufacturing capabilities to commercialize ZYFLO CR; patient, physician and third-party payor acceptance of ZYFLO CR as a safe and effective therapeutic product; adverse side effects experienced by patients taking ZYFLO CR; our heavy dependence on the commercial success of ZYFLO CR; our ability to maintain regulatory approvals to market and sell ZYFLO CR; our ability to successfully enter into additional strategic co-promotion, collaboration or licensing transactions on favorable terms, if at all; conducting clinical trials, including difficulties or delays in the completion of patient enrollment, data collection or data analysis; our ability to obtain the substantial additional funding required to conduct our research, development and commercialization activities; our dependence on our strategic collaboration with MedImmune, Inc.; and our ability to obtain, maintain and enforce patent and other intellectual property protection for ZYFLO, ZYFLO CR, our discoveries and our drug candidates. These and other risks are described in greater detail in the "Risk Factors" section of our most recent Quarterly Report on Form 10-Q and other filings that we make with the Securities and E
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
3. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
4. Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
5. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
6. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
7. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
10. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... , Sept. 23, 2014  MEDIMETRIKS PHARMACEUTICALS ... William Resnick have been elected to ... Mr. Lary, who will serve on ... and investment experience to the Company.  Mr. Lary ... Advisors, LLC, a leading institutional investment firm.  Mr. ...
(Date:9/23/2014)... 2014  KemPharm, Inc., a clinical-stage specialty pharmaceutical ... proprietary new molecular entity (NME) prodrugs, announced today ... from Health Canada to begin clinical trials in ... product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen).  KP201 ... moderate to moderately severe pain. The Health Canada ...
Breaking Medicine Technology:Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- Both drinking ... risk factors for alcohol abuse by high school students, ... a survey of high school students who drink, could ... those who already drink, to stop them from becoming ... distinguish between age of first alcohol use and progression ...
(Date:9/23/2014)... Grinnell Mutual seeks submissions from ... the Midwest. Working Together Making It Better will ... with projects positively impacting their communities. , “So ... their communities a better places,” said Grinnell ... Barb Baker. “Their leadership—as coaches, as volunteers, as ...
(Date:9/23/2014)... CORVALLIS, Ore. A recent Oregon survey about an ... into the daily routine of elementary school students found ... students and teachers, and offered clear advantages for overly ... was developed and produced by the Healthy Youth Program ... and is available nationally. , Brain Breaks leads children ...
(Date:9/23/2014)... BC (PRWEB) September 23, 2014 Vancouver ... will now be offering commercial electrical services in Vancouver, ... of operations; whether it is a small maintenance project ... personalize its solution package to meet the needs of ... that the services will be of an affordable price. ...
(Date:9/23/2014)... 2014 SOURCE: Solutions from Our ... were made to Rimidi Diabetes and ... with business solutions to challenges faced by patients and ... collaboration between The Hitachi Foundation, Village ... entrepreneurs with the investment capital, mentoring, and support needed ...
Breaking Medicine News(10 mins):Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... Research &,Design Journal (HERD) is an interdisciplinary, peer-reviewed, ... and practice of,evidence-based healthcare design by disseminating research ... practice. The,vision of HERD is to improve healthcare ... those receiving and giving care., HERD is ...
... IL, April 10, 2008 The American Pain Society (APS), ... second annual Clinical Centers of Excellence in Pain Management ... Six multidisciplinary pain programs were recognized. They are: ... Pain Management Center, Lebanon, NH , ...
... Spanish . , The removal through endoscopy of ... oesophagus can avoid complete extirpation of this part of ... University Hospital of Navarra for the last three years, ... Endoscopy in the Digestive System, organized by the Digestive ...
... then a research team from the University of Reading and ... may have good news for you. , They have found ... age-related deficits in memory, according to a study soon to ... Medicine. The researchers working at the Schools of Food ...
... 10 - Entries for the eighth,annual Michael E. ... Research (FBR) and named after FBR,s chairman, are ... all professional journalists whose reporting,has enhanced public understanding ... humane and responsible use of animal models., ...
... ... Network, STAMFORD, Conn., April ... lower middle-market special situation,and deep value investments, announced today that it has ... with a commitment from funds managed by the investment management,arm of a ...
Cached Medicine News:Health News:The Center for Health Design & Vendome Group Unveil Premiere Issue of Health Environments Research & Design Journal (HERD) - http://www.herdjournal.com 2Health News:American Pain Society announces recipients of Clinical Centers of Excellence Awards 2Health News:American Pain Society announces recipients of Clinical Centers of Excellence Awards 3Health News:Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part 2Health News:Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part 3Health News:Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part 4Health News:Getting forgetful? Then blueberries may hold the key 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2Health News:Atlantic Street Capital Announces First Close 2
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... This convenient, procedural kit contains everything ... the methacholine challenge test quickly and efficiently: ... gas supply tubing, syringe and needle., ... available in the European Community., ,Intended ...
... Hand Held Nebulizer can be held at angles ... has a built in spill column, finger grooves ... medication setups and 7 feet of regular oxygen ... maintain small particle size and sustain optimum mist ...
Medicine Products: